ArticleOncotarget2018

Promiximab-duocarmycin, a new CD56 antibody-drug conjugates, is highly efficacious in small cell lung cancer xenograft models.

Lin Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.